2-aminoaryloxazole compounds as tyrosine kinase inhibitors

Details for Australian Patent Application No. 2004283162 (hide)

Owner AB Science Institut Curie Centre National de la Recherche Scientifique (CNRS)

Inventors Moussy, Alain; Grierson, David; Croisy, Martine; Giethlen, Bruno; Wermuth, Camille; Ciufolini, Marco; Benjahad, Abdellah

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004283162

PCT Pub. Number WO2005/040139

Priority 60/513,214 23.10.03 US

Filing date 22 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 15 December 2011

International Classifications

C07D 263/48 (2006.01) Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040139 Priority application(s): WO2005/040139

15 December 2011 Application Accepted

  Published as AU-B-2004283162

12 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283164-Control of hot rolled product cross section under localized temperature disturbances

2004283160-Alcohol beverage bag